SK287310B6 - Memnopeptidy, spôsob ich prípravy, kompozície, ktoré ich obsahujú a ich použitie ako liečiva - Google Patents

Memnopeptidy, spôsob ich prípravy, kompozície, ktoré ich obsahujú a ich použitie ako liečiva Download PDF

Info

Publication number
SK287310B6
SK287310B6 SK1226-2002A SK12262002A SK287310B6 SK 287310 B6 SK287310 B6 SK 287310B6 SK 12262002 A SK12262002 A SK 12262002A SK 287310 B6 SK287310 B6 SK 287310B6
Authority
SK
Slovakia
Prior art keywords
compound
formula
group
derivative
salt
Prior art date
Application number
SK1226-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK12262002A3 (sk
Inventor
Laszlo Vertesy
Herbert Kogler
Astrid Markus
Matthias Schiell
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of SK12262002A3 publication Critical patent/SK12262002A3/sk
Publication of SK287310B6 publication Critical patent/SK287310B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SK1226-2002A 2000-02-29 2001-02-15 Memnopeptidy, spôsob ich prípravy, kompozície, ktoré ich obsahujú a ich použitie ako liečiva SK287310B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00104114A EP1130027A1 (de) 2000-02-29 2000-02-29 Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
PCT/EP2001/001661 WO2001064715A2 (en) 2000-02-29 2001-02-15 Memno peptides, a process for their preparation and their use

Publications (2)

Publication Number Publication Date
SK12262002A3 SK12262002A3 (sk) 2003-02-04
SK287310B6 true SK287310B6 (sk) 2010-06-07

Family

ID=8167973

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1226-2002A SK287310B6 (sk) 2000-02-29 2001-02-15 Memnopeptidy, spôsob ich prípravy, kompozície, ktoré ich obsahujú a ich použitie ako liečiva

Country Status (30)

Country Link
US (1) US6627604B2 (cs)
EP (2) EP1130027A1 (cs)
JP (1) JP4787449B2 (cs)
KR (1) KR100997073B1 (cs)
CN (1) CN1274715C (cs)
AR (1) AR029808A1 (cs)
AT (1) ATE313556T1 (cs)
AU (2) AU2001250318B2 (cs)
BR (1) BR0108757A (cs)
CA (1) CA2401032C (cs)
CY (1) CY1105550T1 (cs)
CZ (1) CZ303552B6 (cs)
DE (1) DE60116063T2 (cs)
DK (1) DK1261625T3 (cs)
EE (1) EE05406B1 (cs)
ES (1) ES2254394T3 (cs)
HK (1) HK1052712B (cs)
HR (1) HRP20020703B1 (cs)
HU (1) HU228067B1 (cs)
IL (2) IL151458A0 (cs)
ME (1) ME00379B (cs)
MX (1) MXPA02007845A (cs)
NO (1) NO329082B1 (cs)
NZ (1) NZ521036A (cs)
PL (1) PL206818B1 (cs)
RU (1) RU2261254C2 (cs)
SI (1) SI1261625T1 (cs)
SK (1) SK287310B6 (cs)
WO (1) WO2001064715A2 (cs)
ZA (1) ZA200206841B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012016127A1 (de) 2011-08-31 2013-02-28 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308613B1 (it) * 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
DE10050091A1 (de) * 2000-10-09 2002-04-25 Biotechnolog Forschung Gmbh Casein-Peptidfragmente mit wachstumsbeeinflußender Aktivität auf Zellkulturen
ITMI20010129A1 (it) * 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
DE10258650A1 (de) * 2002-12-13 2004-06-24 Aventis Pharma Deutschland Gmbh Neue Spirobenzofuranlactame und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
US7160917B2 (en) * 2002-12-13 2007-01-09 Sanofi-Aventis Deutschland Gmbh Spirobenzofuran lactams and their derivatives, processes for their preparation and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004530A1 (en) * 1993-08-06 1995-02-16 Smithkline Beecham Corporation Endothelin receptor antagonists
JPH07330622A (ja) * 1994-06-06 1995-12-19 Asahi Chem Ind Co Ltd 新規生理活性物質スタキボシンｄ及びその製法
JPH08283118A (ja) * 1995-04-07 1996-10-29 Kao Corp 美白剤
JPH10251262A (ja) * 1997-01-13 1998-09-22 Mercian Corp プロテアーゼ阻害物質およびその製造方法
DE19731571A1 (de) * 1997-07-23 1999-01-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19754082A1 (de) * 1997-12-05 1999-06-10 Knoll Ag Methode zur Bekämpfung der Fettleibigkeit
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012016127A1 (de) 2011-08-31 2013-02-28 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Also Published As

Publication number Publication date
BR0108757A (pt) 2002-12-10
EP1261625A2 (en) 2002-12-04
AU5031801A (en) 2001-09-12
SK12262002A3 (sk) 2003-02-04
US6627604B2 (en) 2003-09-30
RU2002125877A (ru) 2004-01-10
KR20020077508A (ko) 2002-10-11
NO20024105D0 (no) 2002-08-28
IL151458A0 (en) 2003-04-10
HRP20020703B1 (en) 2011-01-31
AR029808A1 (es) 2003-07-16
KR100997073B1 (ko) 2010-11-30
NO20024105L (no) 2002-10-28
EE200200480A (et) 2004-02-16
US20010031857A1 (en) 2001-10-18
MEP59108A (en) 2011-05-10
RU2261254C2 (ru) 2005-09-27
NO329082B1 (no) 2010-08-16
ES2254394T3 (es) 2006-06-16
IL151458A (en) 2008-08-07
EP1130027A1 (de) 2001-09-05
HUP0204584A3 (en) 2005-09-28
SI1261625T1 (sl) 2006-04-30
EP1261625B1 (en) 2005-12-21
JP4787449B2 (ja) 2011-10-05
ME00379B (me) 2011-05-10
ATE313556T1 (de) 2006-01-15
CA2401032C (en) 2012-04-10
WO2001064715A3 (en) 2002-03-21
AU2001250318B2 (en) 2005-09-08
HUP0204584A2 (hu) 2003-04-28
DE60116063D1 (de) 2006-01-26
CA2401032A1 (en) 2001-09-07
NZ521036A (en) 2004-02-27
CY1105550T1 (el) 2010-07-28
WO2001064715A2 (en) 2001-09-07
DK1261625T3 (da) 2006-04-18
CN1406243A (zh) 2003-03-26
CN1274715C (zh) 2006-09-13
ZA200206841B (en) 2003-07-03
HK1052712A1 (en) 2003-09-26
PL206818B1 (pl) 2010-09-30
HRP20020703A2 (en) 2004-12-31
DE60116063T2 (de) 2006-08-03
HU228067B1 (en) 2012-09-28
MXPA02007845A (es) 2002-11-29
JP2004512257A (ja) 2004-04-22
EE05406B1 (et) 2011-04-15
HK1052712B (zh) 2007-01-12
PL358300A1 (en) 2004-08-09
CZ303552B6 (cs) 2012-12-05
CZ20022904A3 (cs) 2002-11-13

Similar Documents

Publication Publication Date Title
HUT58820A (en) Process for producing new polypeptides
DE69222142T2 (de) Neuartige prolyl-endopeptidase-inhibitoren sna-115 und sna-115t, ihre herstellung, und hierbei verwendete stämme
SK68594A3 (en) Lipopeptides made by actinoplanes bacteries, method of their preparing and using
US8476222B2 (en) Isolated peptides from Actinomadura namibiensis
JP2011516048A (ja) アクチノマデュラ・ナミビエンシス由来の高度に架橋したペプチド
JP4620873B2 (ja) Ａｃｒｅｍｏｎｉｕｍｔｕｂａｋｉｉ由来の新規抗寄生虫薬であるセファイボール、その製造方法およびその使用
SK287310B6 (sk) Memnopeptidy, spôsob ich prípravy, kompozície, ktoré ich obsahujú a ich použitie ako liečiva
AU2001250318A1 (en) Memno peptides, a process for their preparation and their use
US5854276A (en) Substance WF16616, process for production thereof, and use thereof
RU2228337C2 (ru) Ванкорезмицин (варианты), его использование, штамм amycolatopsis вида hil-006734 для его получения
EP1136488A1 (en) Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities
EP0818539A1 (en) Methylsulfomycin I, a process for its production and its use
US6642391B2 (en) Amycomycin, a process for its production and its use as a pharmaceutical
US6930130B2 (en) Citrullimycines, a process for their production and their use as pharmaceuticals

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20180215